We are live on ! Find out more
TE

Tema ETFs Portfolio holdings

AUM $3.09B
1-Year Est. Return 72.72%
This Fund
S&P 500
This Quarter Est. Return
+13.47%
1 Year Est. Return
+72.72%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$377M
AUM Growth
+$41.9M
Cap. Flow
+$7.27M
Cap. Flow %
1.93%
Top 10 Hldgs %
20.9%
Holding
176
New
29
Increased
67
Reduced
61
Closed
11

Top Buys

Rank Stock Value
1
ETN icon
Eaton
ETN
+$8.67M
2
CGNX icon
Cognex
CGNX
+$6.97M
3
CRH icon
CRH
CRH
+$5.6M
4
LIN icon
Linde
LIN
+$5.07M
5
JCI icon
Johnson Controls International
JCI
+$3.32M

Sector Composition

Rank Sector Weight
1 Industrials 38.16%
2 Healthcare 30.66%
3 Technology 10.25%
4 Utilities 8.88%
5 Materials 5.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EW icon
101
Edwards Lifesciences
EW
$49.4B
$1.13M 0.3%
14,421
-2,122
-13% -$158K
AEIS icon
102
Advanced Energy
AEIS
$11.4B
$1.12M 0.3%
+8,453
New +$931K
ON icon
103
ON Semiconductor
ON
$34B
$1.11M 0.3%
+21,258
New +$924K
IONS icon
104
Ionis Pharmaceuticals
IONS
$8.99B
$1.11M 0.3%
28,161
+3,020
+12% +$98.8K
IMNM icon
105
Immunome
IMNM
$2.53B
$1.07M 0.29%
+115,431
New +$946K
WAT icon
106
Waters Corp
WAT
$36.2B
$1.06M 0.28%
3,024
+208
+7% +$71.5K
DHR icon
107
Danaher
DHR
$144B
$1.03M 0.27%
5,221
-743
-12% -$144K
IDXX icon
108
Idexx Laboratories
IDXX
$44.8B
$1.03M 0.27%
1,918
+137
+8% +$65.5K
ELV icon
109
Elevance Health
ELV
$80.9B
$1.02M 0.27%
+2,631
New +$1.06M
MCK icon
110
McKesson
MCK
$98.5B
$1.02M 0.27%
1,392
-182
-12% -$128K
MLM icon
111
Martin Marietta Materials
MLM
$33.8B
$998K 0.27%
+1,818
New +$961K
DXCM icon
112
DexCom
DXCM
$29.6B
$995K 0.26%
11,401
-3,870
-25% -$303K
NRIX icon
113
Nurix Therapeutics
NRIX
$2.4B
$924K 0.25%
81,112
+21,966
+37% +$237K
COGT icon
114
Cogent Biosciences
COGT
$6.68B
$845K 0.22%
117,639
+46,076
+64% +$255K
CHD icon
115
Church & Dwight Co
CHD
$23.2B
$815K 0.22%
+8,481
New +$836K
SNDX icon
116
Syndax Pharmaceuticals
SNDX
$2.02B
$808K 0.21%
86,301
+65,132
+308% +$717K
DAWN
117
DELISTED
Day One Biopharmaceuticals
DAWN
$808K 0.21%
124,310
+33,187
+36% +$228K
ANET icon
118
Arista Networks
ANET
$212B
$804K 0.21%
+7,862
New +$680K
CYTK icon
119
Cytokinetics
CYTK
$10.9B
$793K 0.21%
23,996
-8,592
-26% -$299K
ASND icon
120
Ascendis Pharma A/S
ASND
$17.1B
$704K 0.19%
4,078
-2,028
-33% -$330K
IMCR icon
121
Immunocore
IMCR
$1.78B
$697K 0.19%
22,206
+6,778
+44% +$211K
MASI
122
DELISTED
Masimo
MASI
$664K 0.18%
3,949
-594
-13% -$94.9K
ELVN icon
123
Enliven Therapeutics
ELVN
$3.8B
$654K 0.17%
32,579
+8,931
+38% +$169K
ZYME icon
124
Zymeworks
ZYME
$1.78B
$651K 0.17%
51,855
+18,854
+57% +$225K
HCM icon
125
HUTCHMED
HCM
$1.86B
$641K 0.17%
+42,565
New +$622K

Similar funds

Tema ETFs's Q2 2025 Portfolio in Review

As of Q2 2025, Tema ETFs held 176 positions worth $377M, up 13% from $335M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Tema ETFs's Q2 2025 filing shows 29 new, 67 increased, 61 reduced and 11 closed positions. Its largest new stake was Eaton: 28,145 shares worth $10M. The largest sale was Vulcan Materials, an estimated $5.18M.

By sector, the portfolio is most concentrated in Industrials at 38% of assets, down from 43% a quarter earlier, followed by Healthcare and Technology.

  • Tema ETFs's largest Q2 2025 buy was Eaton: 28,145 shares worth $10M.
  • Tema ETFs added most to Entergy in Q2 2025, an estimated $1.59M increase.
  • Tema ETFs's biggest Q2 2025 reduction was Vulcan Materials, cutting an estimated $5.18M.
  • Tema ETFs fully exited WESCO International in Q2 2025, selling an estimated $3.88M.
  • Tema ETFs's ten largest holdings make up 21% of its $377M portfolio in Q2 2025.
  • Tema ETFs opened 29 new positions and closed 11 in Q2 2025.
  • Tema ETFs's portfolio value rose 13% quarter-over-quarter to $377M.

Based on Tema ETFs's 13F filing for Q2 2025, filed 13 Aug 2025.